For your skin
A standout dark-spot fader. It blocks the human pigment-making enzyme more strongly than most brighteners, so with daily use it visibly lightens melasma, sun spots, and post-acne marks over a few weeks. Pairs well with sunscreen and niacinamide.
Want the science? Keep reading ↓Mechanism of action
A resorcinol derivative identified by screening over 50,000 compounds as the most potent inhibitor of human tyrosinase, the rate-limiting enzyme in melanin synthesis; it suppresses pigment production at the source rather than only fading existing spots.
Why we tier this moderate
2 cited papers across 2 countries. The mechanism is well-described and there's at least one controlled trial in the literature, but we tier this Moderate rather than Strong to stay honest about how many specific papers we cite directly.
Cited research
Klein PA, Kincaid C, Babadjouni A, Mesinkovska NA, Isobutylamido Thiazolyl Resorcinol (Thiamidol) for Combatting Hyperpigmentation: A Systematic Review of Clinical Studies, J Drugs Dermatol 2024;23(11):986-991 — review of 14 studies / 564 subjects across melasma, PIH and solar lentigines: all showed statistically significant improvement
Roggenkamp D, Dlova N, Mann T, Batzer J, Riedel J, Kausch M, Zoric I, Kolbe L, Effective reduction of post-inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido-thiazolyl-resorcinol (Thiamidol), Int J Cosmet Sci 2021;43(3):292-301 — 12-week clinical study in darker skin types: significant reduction in post-inflammatory hyperpigmentation, safe and effective
Sources: PubMed · KCI · J-Stage · CNKI · Wanfang · SFD · MFDS · Cochrane · SCCS · CIR. Every entry points to a specific document. See methodology for what each outcome label means.